Merit Medical [MMSI] vs Baxter International [BAX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Merit Medical Systems, Inc. wins in 12 metrics, Baxter International Inc. wins in 8 metrics, with 0 ties. Merit Medical Systems, Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Merit Medical Systems, Inc. | Baxter International Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.73 | 86.31 | Merit Medical Systems, Inc. |
| Price-to-Book Ratio | 2.62 | 1.54 | Baxter International Inc. |
| Debt-to-Equity Ratio | 51.86 | 160.28 | Merit Medical Systems, Inc. |
| PEG Ratio | 0.98 | 0.73 | Baxter International Inc. |
| EV/EBITDA | 14.25 | 8.55 | Baxter International Inc. |
| Profit Margin (TTM) | 8.48% | -8.51% | Merit Medical Systems, Inc. |
| Operating Margin (TTM) | 15.79% | 7.36% | Merit Medical Systems, Inc. |
| EBITDA Margin (TTM) | 15.79% | 7.36% | Merit Medical Systems, Inc. |
| Return on Equity | 8.67% | -13.71% | Merit Medical Systems, Inc. |
| Return on Assets (TTM) | 4.75% | 2.83% | Merit Medical Systems, Inc. |
| Free Cash Flow (TTM) | $212.54M | $323.00M | Baxter International Inc. |
| Dividend Yield | N/A | 1.77% | N/A |
| 1-Year Return | -28.44% | -31.87% | Merit Medical Systems, Inc. |
| Price-to-Sales Ratio (TTM) | 2.74 | 0.85 | Baxter International Inc. |
| Enterprise Value | $4.52B | $17.26B | Baxter International Inc. |
| EV/Revenue Ratio | 2.98 | 1.54 | Baxter International Inc. |
| Gross Profit Margin (TTM) | 49.59% | 19.40% | Merit Medical Systems, Inc. |
| Revenue per Share (TTM) | $26 | $22 | Merit Medical Systems, Inc. |
| Earnings per Share (Diluted) | $2.13 | $-1.75 | Merit Medical Systems, Inc. |
| Beta (Stock Volatility) | 0.65 | 0.62 | Baxter International Inc. |
| Short % of Float | 6.92% | 12.33% | Merit Medical Systems, Inc. |
Merit Medical Systems, Inc. vs Baxter International Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Merit Medical Systems, Inc. | 0.62% | 1.38% | 9.09% | -3.22% | -22.53% | -22.57% |
| Baxter International Inc. | -0.24% | 8.16% | 20.29% | 21.84% | 6.55% | 6.72% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Merit Medical Systems, Inc. | -28.44% | -20.11% | 10.44% | 251.45% | 269.61% | 604.02% |
| Baxter International Inc. | -31.87% | -54.01% | -74.19% | -53.06% | -34.17% | 1.07% |
Performance & Financial Health Analysis: Merit Medical Systems, Inc. vs Baxter International Inc.
| Metric | MMSI | BAX |
|---|---|---|
| Market Information | ||
| Market Cap | $4.09B | $9.38B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 517,026 | 6,387,585 |
| 90 Day Avg. Volume | 736,832 | 7,931,785 |
| Last Close | $66.94 | $20.81 |
| 52 Week Range | $59.74 - $96.74 | $15.73 - $31.76 |
| % from 52W High | -30.80% | -34.48% |
| All-Time High | $111.45 (Jan 27, 2025) | $95.19 (Apr 20, 2020) |
| % from All-Time High | -39.94% | -78.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.08% |
| Quarterly Earnings Growth | 0.36% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | -0.09% |
| Operating Margin (TTM) | 0.16% | 0.07% |
| Return on Equity (TTM) | 0.09% | -0.14% |
| Debt to Equity (MRQ) | 51.86 | 160.28 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $26.66 | $11.92 |
| Cash per Share (MRQ) | $7.51 | $3.82 |
| Operating Cash Flow (TTM) | $297.37M | $845.00M |
| Levered Free Cash Flow (TTM) | $179.71M | $2.43B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.77% |
| Last 12-Month Dividend | N/A | $0.36 |
Valuation & Enterprise Metrics Analysis: Merit Medical Systems, Inc. vs Baxter International Inc.
| Metric | MMSI (Apr 24, 2026) | BAX (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.73 | 86.31 |
| Forward P/E | 15.88 | 9.09 |
| PEG Ratio | 0.98 | 0.73 |
| Price to Sales (TTM) | 2.74 | 0.85 |
| Price to Book (MRQ) | 2.62 | 1.54 |
| Market Capitalization | ||
| Market Capitalization | $4.09B | $9.38B |
| Enterprise Value | $4.52B | $17.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.98 | 1.54 |
| Enterprise to EBITDA | 14.25 | 8.55 |
| Risk & Other Metrics | ||
| Beta | 0.65 | 0.62 |
| Book Value per Share (MRQ) | $26.66 | $11.92 |
Financial Statements Comparison: Merit Medical Systems, Inc. vs Baxter International Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MMSI (2025) | BAX (2025) |
|---|---|---|
| Revenue/Sales | 1.52B | 11.24B |
| Cost of Goods Sold | 777.64M | 7.87B |
| COGS % of Revenue | 51.3% | 69.9% |
| Gross Profit | 738.27M | 3.38B |
| Gross Margin | 48.7% | 30.1% |
| Research & Development | 97.35M | 518.00M |
| Operating Income (EBIT) | 185.70M | 177.00M |
| Operating Margin | 12.3% | 1.6% |
| EBITDA | 333.03M | 1.26B |
| EBITDA Margin | 22.0% | 11.2% |
| Pre-Tax Income | 170.94M | -505.00M |
| Pre-Tax Income % of Revenue | 11.3% | -4.5% |
| Income Tax | 42.45M | 395.00M |
| Income Tax % of Revenue | 2.8% | 3.5% |
| Net Income (Profit) | 128.49M | -957.00M |
| Profit Margin | 8.5% | -8.5% |
Balance Sheet & Liquidity Metrics
| Metric | MMSI (2025) | BAX (2025) |
|---|---|---|
| Cash & Equivalents | 446.40M | 1.97B |
| Total Current Assets | 1.04B | 6.87B |
| Total Current Assets % of Revenue | 68.6% | 61.1% |
| Total Current Liabilities | 239.76M | 2.97B |
| Total Current Liabilities % of Revenue | 15.8% | 26.4% |
| Long-Term Debt | 810.70M | 9.70B |
| Long-Term Debt % of Revenue | 53.5% | 86.2% |
| Total Shareholders Equity | 1.58B | 6.10B |
| Retained Earnings | 824.03M | 13.71B |
| Retained Earnings % of Revenue | 54.4% | 121.9% |
| Property, Plant & Equipment | 452.88M | 651.00M |
Cash Flow Statement Comparison
| Metric | MMSI (2025) | BAX (2025) |
|---|---|---|
| Operating Cash Flow | 279.65M | -24.00M |
| Operating Cash Flow % of Revenue | 18.4% | -0.2% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | 212.54M | 323.00M |
| FCF Margin | 14.0% | 2.9% |
| Debt Repayment | 0 | -5.79B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MMSI | BAX |
|---|---|---|
| Shares Short | 3.05M | 40.31M |
| Short Ratio | 3.65 | 4.11 |
| Short % of Float | 6.92% | 12.33% |
| Shares Outstanding | 59.42M | 514.28M |
| Float Shares | 58.09M | 512.05M |
| % Held by Insiders | 2.37% | 0.32% |
| % Held by Institutions | 107.03% | 109.89% |
| % Held by Public | -9.40% | -10.21% |
Dividend Analysis & Yield Comparison: Merit Medical Systems, Inc. vs Baxter International Inc.
| Metric | MMSI | BAX |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.36 |
| Last 12-Month Dividend Yield | N/A | 1.77% |
| 3-Year Avg Annual Dividend | N/A | $0.81 |
| 3-Year Avg Dividend Yield | N/A | 0.57% |
| 3-Year Total Dividends | N/A | $2.44 |
| Ex-Dividend Date | N/A | Feb 27, 2026 |